Wednesday, July 8, 2026
🇺🇸 FDA

pharma · Relapsed/Refractory Diffuse Large B-cell Lymphoma · Non-muscle invasive bladder cancer (NMIBC)

Shanghai Antengene Corporation

Shanghai Antengene Corporation Limited

Shanghai Antengene Corporation patent portfolio — 53 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

SAINT-LAURENT, CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
SAINT-LAURENT, CN
Programs
3
Drugs
8
Patents
53
All projects Drug pipeline Patents News & analysis

Recent coverage

View all news & analysis →
Intelligence · Patents

Shanghai Antengene Corporation patents

53 pharmaceutical patents indexed for Shanghai Antengene Corporation. 1 expire within 24 months.

Shanghai Antengene Corporation has 53 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 1 expire within 24 months — use filters for patent-cliff planning.

All patents Expiring ≤12 months Expiring ≤24 months

53 patents

Patent portfolio

Page 1 of 2

  1. US 12421273

    Ectonucleotidase inhibitors and methods of use thereof

    Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12414968

    Compositions comprising bacterially derived minicells and methods of using the same

    Expires Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12357687

    Compositions and vaccines for treating and/or preventing viral infections, and methods of using the same

    Expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12337033

    Encapsulated glycolipid antigens for treatment of neoplastic diseases

    Expires Mon Jun 19 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12076418

    Dually derivatized chitosan nanoparticles and methods of making and using the same for gene transfer in vivo

    Expires Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11964021

    Bacterially derived, intact minicells for delivery of therapeutic agents to brain tumors

    Expires Mon Apr 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11883433

    Chimeric antigen receptor comprising anti-mesothelin scFv, and use thereof

    Expires Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11858957

    Ectonucleotidase inhibitors and methods of use thereof

    Expires Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11795215

    Anti-mesothelin chimeric antigen receptor specifically binding to mesothelin

    Expires Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11623011

    Dually derivatized chitosan nanoparticles and methods of making and using the same for gene transfer in vivo

    Expires Mon Apr 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11504402

    Compositions comprising bacterially derived minicells and methods of using the same

    Expires Mon Nov 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11485976

    Bacterial minicells for delivering nucleic acid adjuvants and methods of using the same

    Expires Mon Oct 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11357860

    Targeted delivery of drugs, therapeutic nucleic acids and functional nucleic acids to mammalian cells via intact killed bacterial cells

    Expires Mon Jun 09 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11147883

    Targeted delivery of drugs, therapeutic nucleic acids and functional nucleic acids to mammalian cells via intact killed bacterial cells

    Expires Mon Oct 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11052157

    Enhanced loading of intact, bacterially derived vesicles with small molecule compounds

    Expires Mon Jul 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11015205

    Oligomeric vaccines from plants by S-Tag-S-protein fusions

    Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 10994014

    Bacterially derived, intact minicells for delivery of therapeutic agents to brain tumors

    Expires Mon Apr 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 10799461

    Methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells

    Expires Mon Oct 08 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 10647785

    High concentration chitosan-nucleic acid polyplex compositions

    Expires Mon May 07 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 10583200

    Targeted gene delivery to non-phagocytic mammalian cells via bacterially derived intact minicells

    Expires Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 10500277

    Combination tumor treatment with drug-loaded, bispecific ligand-targeted minicells and interferon-gamma

    Expires Mon Dec 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 10441546

    Bacterially derived intact minicells that encompass plasmid free DNA and methods of using the same

    Expires Mon Oct 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 10426736

    Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells

    Expires Mon Sep 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 10383827

    Bacterially-derived, intact minicells that encompass plasmid-free functional nucleic acid for in vivo delivery to mammalian cells

    Expires Mon Aug 15 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 10328159

    Enhanced loading of intact, bacterially derived vesicles with small molecule compounds

    Expires Mon Jun 20 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 10098847

    Bacterially-derived, intact minicells that encompass plasmid-free functional nucleic acid for in vivo delivery to mammalian cells

    Expires Mon Oct 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 10076545

    Pharmaceutically compatible method for purifying intact bacterial minicells

    Expires Mon Sep 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 9987377

    Targeted gene delivery to non-phagocytic mammalian cells via bacterially derived intact minicells

    Expires Mon May 31 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 9878043

    Targeted delivery of drugs, therapeutic nucleic acids and functional nucleic acids to mammalian cells via intact killed bacterial cells

    Expires Mon Jan 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 9867785

    Methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells

    Expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 9850323

    High concentration chitosan-nucleic acid polyplex compositions

    Expires Mon Dec 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 9844598

    Bacterially derived, intact minicells for delivery of therapeutic agents to brain tumors

    Expires Mon Dec 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 9730897

    Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells

    Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 9731011

    Combination tumor treatment with drug-loaded, bispecific ligand-targeted minicells and interferon-gamma

    Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 9623112

    Dually derivatized chitosan nanoparticles and methods of making and using the same

    Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 9404088

    Chitosan-based non-viral methods for transfecting gut cells in vivo

    Expires Mon Jul 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 9242007

    Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells

    Expires Mon Jan 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 9169495

    Targeted gene delivery to non-phagocytic mammalian cells via bacterially derived intact minicells

    Expires Mon Oct 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 9066982

    Bacterially-derived, intact minicells that encompass plasmid-free functional nucleic acid for in vivo delivery to mammalian cells

    Expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8956864

    Bacterially derived intact minicells that encompass plasmid free functional nucleic acid for in vivo delivery to mammalian cells

    Expires Mon Feb 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8846102

    Non-viral compositions and methods for transfecting gut cells in vivo

    Expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8772013

    Methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells

    Expires Mon Jul 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8735566

    Bacterially derived intact minicells that encompass plasmid free functional nucleic acid for in vivo delivery to mammalian cells

    Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8722646

    High concentration chitosan-nucleic acid polyplex compositions

    Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8691963

    Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells

    Expires Mon Apr 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8669101

    Bacterially derived intact minicells that encompass plasmid free functional nucleic acid for in vivo delivery to mammalian cells

    Expires Mon Mar 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8591862

    Targeted delivery of drugs, therapeutic nucleic acids and functional nucleic acids to mammalian cells via intact killed bacterial cells

    Expires Mon Nov 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8449877

    Pharmaceutically purified intact bacterial minicells

    Expires Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Shanghai Antengene Corporation have?

53 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Shanghai Antengene Corporation patents expire?

1 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.